Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients

被引:303
作者
Colodner, R [1 ]
Rock, W
Chazan, B
Keller, N
Guy, N
Sakran, W
Raz, R
机构
[1] HaEmek Med Ctr, Clin Microbiol Lab, IL-18101 Afula, Israel
[2] HaEmek Med Ctr, Infect Dis Unit, IL-18101 Afula, Israel
[3] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel
[4] HaEmek Med Ctr, Dept Family Med, IL-18101 Afula, Israel
[5] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
关键词
D O I
10.1007/s10096-003-1084-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although the risk factors for acquiring infection by extended-spectrum beta-lactamase (ESBL)-producing bacteria have been investigated in hospitalized patients, such risk factors have not been defined in the community setting. In this study, clinical data from a total of 311 nonhospitalized patients with community-acquired urinary tract infection (128 with ESBL-positive strains and 183 with ESBL-negative strains) were obtained. According to a multivariate analysis, the following were identified as independent risk factors: previous hospitalization in the past 3 months (OR=8.95, 95%CI, 3.77-21.25), antibiotic treatment in the past 3 months (OR=3.23, 95%CI, 1.76-5.91), age over 60 years (OR=2.65, 95%CI, 1.45-4.83), diabetes (OR=2.57, 95%CI, 1.20-5.51), male gender (OR=2.47, 95%CI, 1.22-5.01), Klebsiella pneumoniae infection (OR=2.31, 95%CI, 1.17-4.54), previous use of third-generation cephalosporins (P=0.014, OR=15.8, 95%CI, 1.7-143), previous use of second-generation cephalosporins (P<0.0001, OR=10.1, 95%CI, 4.2-24), previous use of quinolones (P=0.001, OR=4.1, 95%CI, 1.8-9.0), and previous use of penicillin (P=0.003, OR=4.0, 95%CI, 1.6-9.0).
引用
收藏
页码:163 / 167
页数:5
相关论文
共 19 条
[1]   Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain [J].
Barrett, SP ;
Savage, MA ;
Rebec, MP ;
Guyot, A ;
Andrews, N ;
Shrimpton, SB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (03) :359-365
[2]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella species:: Risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence [J].
Bisson, G ;
Fishman, NO ;
Patel, JB ;
Edelstein, PH ;
Lautenbach, E .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (05) :254-260
[3]  
Borer A, 2002, MED SCI MONITOR, V8, pCR44
[5]  
CLARRIDGE JE, 1998, CUMITECH B, V2
[6]   Antimicrobial susceptibility of community-acquired uropathogens in northern Israel [J].
Colodner, R ;
Keness, Y ;
Chazan, B ;
Raz, R .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (02) :189-192
[7]  
HO PL, 2002, PHARMACOTHERAPY, V22, P14
[8]  
JACOBY GA, 1988, NEW ENGL J MED, V319, P723
[9]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[10]   A 5-year epidemiological study of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit [J].
Mangeney, N ;
Niel, P ;
Paul, G ;
Faubert, E ;
Hue, S ;
Dupeyron, C ;
Louarn, F ;
Leluan, G .
JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 (03) :504-511